THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

NASDAQ / LIVE COMPANY INTELLIGENCE

Akebia Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERAKBA

CORENasdaq-listed company

WATCHEarnings + filings + operating news

STATUSContinuously updated

LIVE / AKBA COVERAGE

What’s moving Akebia Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

Akebia Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026

Investors are testing whether Akebia Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.

Transcript : Akebia Therapeutics, Inc., Q3 2026 Earnings Call, Nov 05, 2026

Investors are testing whether Akebia Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.

Akebia Therapeutics, Inc. (AKBA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

The story matters when it changes Akebia Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.

Akebia Therapeutics, Inc. Scheduled to Report Q4 and Full Year 2024 Financial Results on March 13, 2025

The story matters when it changes Akebia Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.

Akebia Therapeutics, Inc. (AKBA) Q3 2024 Earnings Call Transcript

Investors are testing whether Akebia Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.

PRIMARY DOCUMENTS / SEC EDGAR

Latest AKBA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-11-05 · Period 2026-09-30SEC ↗10-QQuarterly financial reportFiled 2026-08-05 · Period 2026-06-30SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-11-05 · Period 2026-11-05SEC ↗8-KMaterial company eventFiled 2026-10-23 · Period 2026-10-21SEC ↗8-KMaterial company eventFiled 2026-10-14 · Period 2026-10-07SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-28 · Period 2026-04-28SEC ↗4Official SEC filingFiled 2026-08-10 · Period 2026-08-06SEC ↗

EARNINGS / QUARTERLY TRACKER